These are likely to dominate the future antibody therapeutic market, but many of them express poorly and have aggregation issues leading to delays to projects. Fusion Antibodies utilizes unique ...
The first application-specific module to be added to the new Streamline MP software suite is Refeyn’s Antibody Stability Module, which automatically characterizes aggregation in large batches of ...